Catalysis is an essential component in modern pharmaceutical manufacturing, enabling the efficient production of complex drugs and advancing the development of new therapeutic agents. Catalysis in medicine and pharmaceuticals is used to accelerate chemical reactions, enhancing reaction rates and selectivity while minimizing the need for harsh reaction conditions, toxic solvents, and excessive by-products. This is particularly important for the synthesis of high-value, low-volume drugs, where maximizing yield and minimizing waste are key considerations. Catalysis also plays a critical role in the synthesis of chiral compounds, which are crucial for creating effective pharmaceuticals with the desired biological activity. Asymmetric catalysis, which enables the selective formation of one stereoisomer over another, has revolutionized the production of chiral drugs and is now routinely used in the synthesis of many widely prescribed medications. In addition to small-molecule drugs, catalysis is also being applied to the development of biologics, such as therapeutic proteins and gene therapies. Enzyme-based catalysis, for example, can help with the efficient modification and production of monoclonal antibodies and other biologic therapeutics. Catalysts are also used in the synthesis of prodrugs, which are inactive compounds that are converted into their active form once administered to the body, offering improved drug delivery profiles and reduced side effects. The integration of catalysis into pharmaceutical manufacturing processes not only improves the efficiency of drug production but also enables the development of more sustainable and environmentally friendly processes, which are critical in meeting the growing demand for healthcare solutions.
Title : Human impact on natural environment and its implications
Dai Yeun Jeong, Asia Climate Change Education Center, Korea, Republic of
Title : Personalized and Precision Medicine PPM as a unique healthcare model through biodesign inspired and biotech driven translational applications and upgraded business marketing to secure the human healthcare and biosafety
Sergey Suchkov, R&D Director of the National Center for Human Photosynthesis, Mexico
Title : Thermomechanical processes and transformations governing reversibility in shape memory alloys
Osman Adiguzel, Firat University, Turkey
Title : Design of nanocomposite materials for active components of structured catalysts for biofuels transformation into syngas, catalytic layers of membrane reactors with oxygen/hydrogen separation and anodes of solid oxide fuels cells operating in the internal reforming mode
Vladislav Sadykov, Boreskov Institute of Catalysis, Russian Federation
Title : Effect of bed material on syngas quality: Comparison of biomass gasification with different bed materials
Enrico Paris, CREA-IT & DIAEE, Italy
Title : Solar heterogeneous photocatalysis and photochemistry for urban wastewater regeneration and reuse
Isabel Oller Alberola, Plataforma Solar de Almería, Spain
Title : 30,000 nano implants in humans with no infections, no loosening, and no failures
Thomas J Webster, Interstellar Therapeutics, United States
Title : Perspective of ruthenium complex catalyst system for selective oxidation of methane
Ram Sambhar Shukla, CSIR-Central Salt and Marine Chemicals Research Institute (CSMCRI), India
Title : Multi-component heterostructures for scalable green H2 production using overall catalysis
Tokeer Ahmad, Jamia Millia Islamia, India
Title : Research progress and future development trend of plasma technology in the field of mercury removal from flue gas
Ying Li, School of Energy and Power Engineering Jiangsu University, China